🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ocular Microbiome and Immune System in Dry Eyes

Recruitingn/aAges 18 Years - anyAllInsel Gruppe AG, University Hospital Bern
NCT04658238 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary objectives of this study are the characterization of the ocular microbiome as well as of the local immune system in participants with and without dry eye disease. Secondary objectives are the identification of differences in the ocular microbiome as well as in the immune system between participants with and without dry eye disease to ultimately find associations between the ocular microbiome and the immune system in dry eye disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Willing to sign informed consent * 18 years of age or older Exclusion Criteria: * Not willing or able to sign informed consent * Younger than 18 years * Recent (3 month) history of use of systemic and/or topical antibiotics * Usage of medical eye drops (Lacrycon and other moisturizing eye drops are allowed) * Recent (3 month) history of ocular surgery
💊

What it tests

  • Ocular microbiome
  • Ocular immune system
📍

Where

1 site
Department of Ophthalmology, Inselspital
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy